Moderna’s mResvia is now the third FDA-approved RSV vaccine and the first one based on mRNA technology. It will compete for market share against RSV shots from GSK and Pfizer that won their FDA nods last year.
The post FDA Approves Moderna RSV Vaccine, an mRNA Alternative to GSK and Pfizer Products appeared first on MedCity News.
Recent Posts
Categories
Related Articles
When It Comes to AI, Rural Doctors Have FOMO — Meditech & Suki Are Teaming Up to Address This
Meditech is integrating Suki’s AI assistant into more than a dozen rural...
FTC to sue PBMs over insulin pricing and rebates
From the FTC’s press release out today: Today, the Federal Trade Commission...
World Mental Health Day 2024
Every year, World Mental Health Day is an opportunity for mental health...
North Carolina’s Effort to Relieve Medical Debt
This policy watch examines the burden of medical debt in North Carolina...
Leave a comment